Abstract: The pharmaceutical compositions for oral administration according to the invention contain 0.5% to 20% of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form, and pharmaceutical excipients; they are formulated by wet granulation.
Type:
Grant
Filed:
May 1, 2002
Date of Patent:
May 17, 2005
Assignee:
Sanoti-Synthelabo
Inventors:
Bernard Abramovici, Christian Condamine, Jean-Claude Gromenil